Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-16

Clinical Trial Update: Rate Control in Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating rate control in atrial fibrillation is sponsored by Creighton University. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Creighton University | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN